Suivre
Filippo Alongi
Filippo Alongi
Direttore Radioterapia Oncologica, Ospedale Sacro Cuore, Negrar (Verona)
Adresse e-mail validée de sacrocuore.it
Titre
Citée par
Citée par
Année
MR-guidance in clinical reality: current treatment challenges and future perspectives
S Corradini, F Alongi, N Andratschke, C Belka, L Boldrini, F Cellini, ...
Radiation Oncology 14, 1-12, 2019
2982019
Review and uses of stereotactic body radiation therapy for oligometastases
F Alongi, S Arcangeli, AR Filippi, U Ricardi, M Scorsetti
The oncologist 17 (8), 1100-1107, 2012
2232012
Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial
M Scorsetti, S Arcangeli, A Tozzi, T Comito, F Alongi, P Navarria, ...
International Journal of Radiation Oncology* Biology* Physics 86 (2), 336-342, 2013
2152013
Volumetric modulated arc therapy with flattening filter free (FFF) beams for stereotactic body radiation therapy (SBRT) in patients with medically inoperable early stage non …
P Navarria, AM Ascolese, P Mancosu, F Alongi, E Clerici, A Tozzi, C Iftode, ...
Radiotherapy and Oncology 107 (3), 414-418, 2013
1762013
IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy
F Alongi, C Fiorino, C Cozzarini, S Broggi, L Perna, GM Cattaneo, ...
Radiotherapy and Oncology 93 (2), 207-212, 2009
1542009
Linac-based VMAT radiosurgery for multiple brain lesions: comparison between a conventional multi-isocenter approach and a new dedicated mono-isocenter technique
R Ruggieri, S Naccarato, R Mazzola, F Ricchetti, S Corradini, A Fiorentino, ...
Radiation Oncology 13, 1-9, 2018
1512018
Radical radiation therapy for oligometastatic breast cancer: results of a prospective phase II trial
M Trovo, C Furlan, J Polesel, F Fiorica, S Arcangeli, N Giaj-Levra, ...
Radiotherapy and Oncology 126 (1), 177-180, 2018
1442018
Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments
M Scorsetti, F Alongi, S Castiglioni, A Clivio, A Fogliata, F Lobefalo, ...
Radiation oncology 6, 1-8, 2011
1442011
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study
L Triggiani, F Alongi, M Buglione, B Detti, R Santoni, A Bruni, ...
British journal of cancer 116 (12), 1520-1525, 2017
1432017
Neuroendocrine carcinoma of the breast: current evidence and future perspectives
A Inno, G Bogina, M Turazza, L Bortesi, S Duranti, A Massocco, ...
The Oncologist 21 (1), 28-32, 2016
1362016
Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study
F Alongi, L Cozzi, S Arcangeli, C Iftode, T Comito, E Villa, F Lobefalo, ...
Radiation Oncology 8, 1-8, 2013
1252013
Current status and recent advances in reirradiation of glioblastoma
G Minniti, M Niyazi, F Alongi, P Navarria, C Belka
Radiation Oncology 16, 1-14, 2021
1192021
SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience
A Tozzi, T Comito, F Alongi, P Navarria, C Iftode, P Mancosu, G Reggiori, ...
Radiation Oncology 8, 1-8, 2013
1162013
Metastasis-directed therapy in treating nodal oligorecurrent prostate cancer: a multi-institutional analysis comparing the outcome and toxicity of stereotactic body …
E De Bleser, BA Jereczek-Fossa, D Pasquier, T Zilli, N Van As, S Siva, ...
European urology 76 (6), 732-739, 2019
1142019
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
P Navarria, AM Ascolese, S Tomatis, L Cozzi, F De Rose, P Mancosu, ...
Radiation Oncology 9, 1-8, 2014
1132014
Significant reduction of acute toxicity following pelvic irradiation with helical tomotherapy in patients with localized prostate cancer
C Cozzarini, C Fiorino, N Di Muzio, F Alongi, S Broggi, M Cattaneo, ...
Radiotherapy and oncology 84 (2), 164-170, 2007
1132007
Mastectomy or breast-conserving therapy for early breast cancer in real-life clinical practice: outcome comparison of 7565 cases
S Corradini, D Reitz, M Pazos, S Schönecker, M Braun, N Harbeck, ...
Cancers 11 (2), 160, 2019
1082019
1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment
F Alongi, M Rigo, V Figlia, F Cuccia, N Giaj-Levra, L Nicosia, F Ricchetti, ...
Radiation Oncology 15, 1-9, 2020
1052020
Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of …
M Scorsetti, F Alongi, A Fogliata, S Pentimalli, P Navarria, F Lobefalo, ...
Radiation oncology 7, 1-8, 2012
1022012
Dose–volume relationships for acute bowel toxicity in patients treated with pelvic nodal irradiation for prostate cancer
C Fiorino, F Alongi, L Perna, S Broggi, GM Cattaneo, C Cozzarini, ...
International Journal of Radiation Oncology* Biology* Physics 75 (1), 29-35, 2009
1002009
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20